Improvement in long-term memory following chronic administration of eryngium planum root extract in scopolamine model: Behavioral and molecular study

Evidence-based Complementary and Alternative Medicine

Volumn 2015, Issue , 2015, Pages

  Ozarowski, Marcin ^a,b   Thiem, Barbara ^a   Mikolajczak, Przemyslaw L ^a,b   Piasecka, Anna ^c   Kachlicki, Piotr ^c   Szulc, Michal ^a   Kaminska, Ewa ^a   Bogacz, Anna ^a,b   Kujawski, Radoslaw ^b   Bartkowiak Wieczorek, Joanna ^a,b   Kujawska, Malgorzata ^a   Jodynis Liebert, Jadwiga ^a   Budzianowski, Jaromir ^a   Kędziora, Izabela ^a   Seremak Mrozikiewicz, Agnieszka ^a,b   Czerny, Boguslaw ^b,d   Bobkiewicz Kozłowska, Teresa ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b INSTITUTE OF NATURAL FIBRES AND MEDICINAL PLANTS   (Poland)

^c INSTITUTE OF PLANT GENETICS   (Poland)

^d POMERANIAN MEDICAL UNIVERSITY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYL GLUCOSIDE TRITERPENOID; ACETYLCHOLINESTERASE; BARRINGENOL R1 TETRAGLUCOSIDE; BARRINGTOGENOL C TRIGLUCOSIDE; BETA SECRETASE; BETULINIC ACID GLUCOSIDE; CAFFEIC ACID GLUCOSIDE; CAFFEIC ACID TRIGLUCOSIDE; CHOLINESTERASE; DECAFFEINATE; ERYNGIUM PLANUM EXTRACT; FERULIC ACID DERIVATIVE; GLUCOSIDE TRITERPENOID; HEX HEX TRITERPENOID ACID; HEX TRITERPENOID ACID; MESSENGER RNA; P COUMARIC ACID DIGLUCOSIDE; P COUMARIC ACID PENTOSIDE; PLANT EXTRACT; ROSMARINIC ACID; ROSMARINIC ACID DIGLUCOSIDE; ROSMARINIC ACID GLUCURONIDE; ROSMARINIC ACID PENTOSIDE; ROSMARINIC ACID TRIGLUCOSIDE; SCOPOLAMINE; TRITERPENOID SAPONIN; TRYPTOPHAN; TYROSINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; BRAIN REGION; COGNITION; CONTROLLED STUDY; DRUG DETERMINATION; DRUG SCREENING; ERYNGIUM PLANUM; GENE EXPRESSION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LEARNING AND MEMORY TEST; LIMIT OF QUANTITATION; LOCOMOTION; LONG TERM CARE; LONG TERM MEMORY; MASS SPECTROMETRY; MEDICINAL PLANT; MOTOR COORDINATION; NONHUMAN; OBJECT RECOGNITION TEST; PASSIVE AVOIDANCE TEST; PLANT ROOT; PRIORITY JOURNAL; RAT; REAL TIME POLYMERASE CHAIN REACTION; THIN LAYER CHROMATOGRAPHY; WISTAR RAT;

EID: 84943328774     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2015/145140     Document Type: Article

References (60)

1. S. Davinelli, N. Sapere, D. Zella, R. Bracale, M. Intrieri, and G. Scapagnini, "Pleiotropic protective effects of phytochemicals in Alzheimer's disease. OxidativeMedicine and Cellular Longevity. vol. 2012, Article ID386527, 11 pages. 2012.
2. N. G. M. Gomes, M. G. Campos, J. M. C. Órfão, and C. A. F. Ribeiro, "Plants with neurobiological activity as potential targets for drug discovery. Progress in Neuro-Psychopharmacology &Biological Psychiatry. vol. 33. no. 8. pp. 1372-1389. 2009.
3. M. Kadiyala, S. Ponnusankar, and K. Elango, "Screening of siddha medicinal plants for its in-vitro acetylcholinesterase and butyrylcholinesterase inhibitory activity. PharmacognosyMagazine. vol. 10. no. 38. pp. S294-S298. 2014.
4. M. Mathew and S. Subramanian, "In vitro screening for anticholinesterase and antioxidant activity of methanolic extracts of ayurvedic medicinal plants used for cognitive disorders. PLoS ONE. vol. 9. no. 1, Article ID e86804. 2014.
5. M. C. Carpinella, D. G. Andrione, G. Ruiz, and S.M. Palacios, "Screening for acetylcholinesterase inhibitory activity in plant extracts from Argentina. Phytotherapy Research. vol. 24. no. 2. pp. 259-263. 2010.
6. P. K. Mukherjee, V. Kumar, M. Mal, and P. J. Houghton, "Acetylcholinesterase inhibitors from plants. Phytomedicine. vol. 14. no. 4. pp. 289-300. 2007.
7. L.A. Craig, N. S. Hong, and R. J. McDonald, "Revisiting the cholinergic hypothesis in the development of Alzheimer's disease. Neuroscience &Biobehavioral Reviews. vol. 35. no. 6. pp. 1397-1409. 2011.
8. W. Chaiyana and S. Okonogi, "Inhibition of cholinesterase by essential oil fromfood plant. Phytomedicine. vol. 19. no. 8-9. pp. 836-839. 2012.
9. M. Goedert and M. G. Spillantini, "A century of Alzheimer's disease. Science. vol. 314. no. 5800. pp. 777-781. 2006.
10. M. Adams, F. Gmünder, and M. Hamburger, "Plants traditionally used in age related brain disorders-A survey of ethnobotanical literature. Journal of Ethnopharmacology. vol. 113. no. 3. pp. 363-381. 2007.
11. D. Vauzour, "Dietary polyphenols as modulators of brain functions: biological actions and molecularmechanisms underpinning their beneficial effects. OxidativeMedicine and Cellular Longevity. vol. 2012, Article ID 914273, 16 pages. 2012.
12. H. Y. Zhang, C. Y. Zheng, H. Yan, et al., "Potential therapeutic targets of huperzine A for Alzheimer's disease and vascular dementia. Chemico-Biological Interactions. vol. 175. no. 1-3. pp. 396-402. 2008.
13. C. Keller, A. Kadir, A. Forsberg, O. Porras, and A. Nordberg, "Long-Term effects of galantamine treatment on brain functional activities as measured by pet in Alzheimer's disease patients. Journal of Alzheimer's Disease. vol. 24. no. 1. pp. 109-123. 2011.
14. S.-H. Choi, J.-M. Hur, E.-J. Yang, et al., "Beta-secretase (BACE 1) inhibitors from Perilla frutescens var. acuta. Archives of Pharmacal Research. vol. 31. no. 2. pp. 183-187. 2008.
15. D. S. H. L. Kim, J.-Y. Kim, and Y. S. Han, "Alzheimer's disease drug discovery from herbs: neuroprotectivity from -Amyloid (1-42) insult. Journal of Alternative and Complementary Medicine. vol. 13. no. 3. pp. 333-340. 2007.
16. P. Wang, Z. Su, W. Yuan, G. Deng, and S. Li, "Phytochemical constituents and pharmacological activities of Eryngium L. (Apiaceae). Pharmaceutical Crops. vol. 3. no. 1. pp. 99-120. 2012.
17. E. L. Claire, S. Schwaiger, B. Banaigs, H. Stuppner, and F. Gafner, "Distribution of a new rosmarinic acid derivative in Eryngium alpinumL. and otherApiaceae. Journal of Agricultural andFood Chemistry. vol. 53. no. 11. pp. 4367-4372. 2005.
18. J. Hohmann, Z. Páll, G. Günther, and I. Máthe, "Flavonolacyl glycosides of the aerial parts of Eryngium campestre. Planta Medica. vol. 63. no. 1, p. 96. 1997.
19. W. Kholkhal, F. Ilias, C. Bekhechi, and F. Bekkara, "Eryngium maritimum: a rich medicinal plant of polyphenols and flavonoids compounds with antioxidant, antibacterial and antifungal activities. Current Research Journal of Biological Sciences. vol. 4. no. 4. pp. 437-443. 2012.
20. Z. Z. Zhang, S. Y. Li, S. Ownby, et al., "Phenolic compounds and rare polyhydroxylated triterpenoid saponins from Eryngium yuccifolium. Phytochemistry. vol. 69. no. 10. pp. 2070-2080. 2008.
21. C. A. J. Erdelmeier and O. Sticher, "Coumarin derivatives from Eryngium campestre. PlantaMedica. vol. 51. no. 5. pp. 407-409. 1985.
22. B. Thiem, M. Kikowska, A. Kurowska, and D. Kalemba, "Essential oil composition of the different parts and In Vitro shoot culture of Eryngium planum L. Molecules. vol. 16. no. 8. pp. 7115-7124. 2011.
23. L. P. Christensen and K. Brandt, "Bioactive polyacetylenes in food plants of the Apiaceae family: occurrence, bioactivity and analysis. Journal of Pharmaceutical and Biomedical Analysis. vol. 41. no. 3. pp. 683-693. 2006.
24. E. Küpeli, M. Kartal, S. Aslan, and E. Yesilada, "Comparative evaluation of the anti-inflammatory and antinociceptive activity of Turkish Eryngium species. Journal of Ethnopharmacology. vol. 107. no. 1. pp. 32-37. 2006.
25. B. Thiem, O. Goslínska, M. Kikowska, and J. Budzianowski, "Antimicrobial activity of three Eryngium L. species (Apiaceae). Herba Polonica. vol. 56. no. 4. pp. 52-59. 2010.
26. M. D. L. L. Cádiz-Gurrea, S. Fernández-Arroyo, J. Joven, and A. Segura-Carretero, "Comprehensive characterization by UHPLC-ESI-Q-TOF-MS from an Eryngium bourgatii extract and their antioxidant and anti-inflammatory activities. Food Research International. vol. 50. no. 1. pp. 197-204. 2013.
27. B. Thiem, M. Kikowska, A. Krawczyk, B. Wieckowska, and E. Sliwinska, "Phenolic acid and DNA contents of micropropagated Eryngium planum L. Plant Cell, Tissue andOrgan Culture. vol. 114. no. 2. pp. 197-206. 2013.
28. A. Wojakowska, A. Piasecka, P. M. Garćia-Ĺopez, et al., "Structural analysis and profiling of phenolic secondarymetabolites of Mexican lupine species using LC-MS techniques. Phytochemistry. vol. 92. pp. 71-86. 2013.
29. M. Ozarowski, P. L. Mikolajczak, A. Bogacz, et al., "Rosmarinus officinalis L. leaf extract improves memory impairment and affects acetylcholinesterase and butyrylcholinesterase activities in rat brain. Fitoterapia. vol. 91. pp. 261-271. 2013.
30. M. Kowalczyk, M. Masullo, B. Thiem, S. Piacente, A. Stochmal, and W. Oleszek, "Three new triterpene saponins from roots of Eryngium planum. Natural Product Research. vol. 28. no. 9. pp. 653-660. 2014.
31. C. M. Cheng, A. M. M. Jalil, and A. Ismail, "Phenolic and theobromine contents of commercial dark, milk and white chocolates on theMalaysianmarket. Molecules. vol. 14. no. 1. pp. 200-209. 2009.
32. P. J. R. Boissier, J. Tardy, and J. C. Diverres, "Une nouvelle methode simple pour explorer l'action 'tranquillisante': le test de la chemińee. Medicina Experimentalis. vol. 3. no. 1. pp. 81-84. 1960.
33. R. Ader, J. A. W. M. Weijnen, and P. Moleman, "Retention of a passive avoidance response as a function of the intensity and duration of electric shock. Psychonomic Science. vol. 26. no. 3. pp. 125-128. 1972.
34. E. M. Blalock, K.-C. Chen, K. Sharrow, et al., "Gene microarrays in hippocampal aging: statistical profiling identifies novel processes correlated with cognitive impairment. Journal of Neuroscience. vol. 23. no. 9. pp. 3807-3819. 2003.
35. K. Isomae, S. Morimoto, H. Hasegawa, K. Morita, and J. Kamei, "Effects of T-82, a novel acetylcholinesterase inhibitor, on impaired learning and memory in passive avoidance task in rats. European Journal of Pharmacology. vol. 465. no. 1-2. pp. 97-103. 2003.
36. I. Parveen, T. Wilson, I. S. Donnison, A. R. Cookson, B. Hauck, and M.D. Threadgill, "Potential sources of high value chemicals from leaves, stems and flowers of Miscanthus sinensis 'Goliath' andMiscanthus sacchariflorus. Phytochemistry. vol. 92. pp. 160-167. 2013.
37. K. Hiller, V. T. Nguyen, G. Lehman, and E. Grundemann, "Saniculoidae components. 21. Betulinic acid, a sapogenin in Eryngium bromelifolium. Pharmazie. vol. 29. no. 2. pp. 148-149. 1974.
38. L.W. Sumner, A. Amberg, D. Barrett, et al., "Proposed minimum reporting standards for chemical analysis working group (CAWG) metabolomics standards initiative (MSI). Metabolomics. vol. 3. no. 3. pp. 211-221. 2007.
39. P. Bhutada, Y. Mundhada, K. Bansod, et al., "Ameliorative effect of quercetin on memory dysfunction in streptozotocin-induced diabetic rats. Neurobiology of Learning andMemory. vol. 94. no. 3. pp. 293-302. 2010.
40. S.-H. Kwon, H.-K. Lee, J.-A. Kim, et al., "Neuroprotective effects of chlorogenic acid on scopolamine-induced amnesia via antiacetylcholinesterase and anti-oxidative activities in mice. European Journal of Pharmacology. vol. 649. no. 1-3. pp. 210-217. 2010.
41. K. Nagpal, S. K. Singh, and D. N. Mishra, "Nanoparticle mediated brain targeted delivery of gallic acid: in vivo behavioral and biochemical studies for protection against scopolamineinduced amnesia. Drug Delivery. vol. 20. no. 3-4. pp. 112-119. 2013.
42. C. A. Zanella, H. Treichel, R. L. Cansian, and S. S. Roman, "The effects of acute administration of the hydroalcoholic extract of rosemary (Rosmarinus officinalis L.) (Lamiaceae) in animal mModels of memory. Brazilian Journal of Pharmaceutical Sciences. vol. 48. no. 3. pp. 389-397. 2012.
43. C.-M. Wang, M.-Y. Liu, F. Wang, et al., "Anti-Amnesic effect of pseudoginsenoside-F11 in two mouse mModels of Alzheimer's disease. Pharmacology Biochemistry and Behavior. vol. 106. pp. 57-67. 2013.
44. E.-J. Kim, I.-H. Jung, T. K. Van Le, J.-J. Jeong, N.-J. Kim, and D.-H. Kim, "Ginsenosides Rg5 and Rh3 protect scopolamineinduced memory deficits in mice. Journal of Ethnopharmacology. vol. 146. no. 1. pp. 294-299. 2013.
45. S. G. Sparg, M. E. Light, and J. van Staden, "Biological activities and distribution of plant saponins. Journal of Ethnopharmacology. vol. 94. no. 2-3. pp. 219-243. 2004.
46. I. D. Peña, S. Y. Yoon, H. J. Kim, et al., "Effects of ginseol kg3, an Rg3-enriched fraction, on scopolamine-inducedmemory impairment and learning deficit in mice. Journal of Ginseng Research. vol. 38. no. 1. pp. 1-7. 2014.
47. Q. Wang, L.-H. Sun, W. Jia, et al., "Comparison of ginsenosides Rg1 and Rb1 for their effects on improving scopolamineinduced learning and memory impairment in mice. Phytotherapy Research. vol. 24. no. 12. pp. 1748-1754. 2010.
48. N. Yamada, A. Hattori, T. Hayashi, T. Nishikawa, H. Fukuda, and T. Fujino, "Improvement of scopolamine-induced memory impairment by Z-Ajoene in the water maze in mice. Pharmacology Biochemistry and Behavior. vol. 78. no. 4. pp. 787-791. 2004.
49. U. Ebert and W. Kirch, "Scopolamine mModel of dementia: electroencephalogram findings and cognitive performance. European Journal of Clinical Investigation. vol. 28. no. 11. pp. 944-949. 1998.
50. S. Jain, T. Sangma, S. K. Shukla, and P. K. Mediratta, "Effect of Cinnamomum zeylanicum extract on scopolamine-induced cognitive impairment and oxidative stress in rats. Nutritional Neuroscience. vol. 18. no. 5. pp. 210-216. 2015.
51. I. Orhan and M. Aslan, "Appraisal of scopolamine-induced antiamnesic effect in mice and in vitro antiacetylcholinesterase and antioxidant activities of some traditionally used Lamiaceae plants. Journal of Ethnopharmacology. vol. 122. no. 2. pp. 327-332. 2009.
52. D. Vohora, S. N. Pal, and K. K. Pillai, "Effect of locomotor activity on the passive avoidance test for the evaluation of cognitive function. Indian Journal of Pharmacology. vol. 32. no. 3. pp. 242-245. 2000.
53. R. Thouvarecq, P. Protais, F. Jouen, and J. Caston, "Influence of cholinergic system on motor learning during aging in mice. Behavioural Brain Research. vol. 118. no. 2. pp. 209-218. 2001.
54. G. T. Ha, R. K. Wong, and Y. Zhang, "Huperzine a as potential treatment of Alzheimer's disease: an assessment on chemistry, pharmacology, and clinical studies. Chemistry &Biodiversity. vol. 8. no. 7. pp. 1189-1204. 2011.
55. M. K. M. Tun and S. B. Herzon, "The pharmacology and therapeutic potential of (-)-huperzine A. Journal of Experimental Pharmacology. vol. 4. pp. 113-123. 2012.
56. W. B. Essman, "Brain 5-hydroxytryptamine and memory consolidation. Advances in Biochemical Psychopharmacolog. vol. 11. pp. 265-274. 1974.
57. J.D. A. Olivier, L. A.W. Jans, A. Blokland, et al., "Serotonin transporter deficiency in rats contributes to impaired object memory. Genes, Brain and Behavior. vol. 8. no. 8. pp. 829-834. 2009.
58. S.-W. Hong, D.-H. Yoo, J.-Y. Woo, J.-J. Jeong, J.-H. Yang, and D.-H. Kim, "Soyasaponins Ab and Bb prevent scopolamineinduced memory impairment in mice without the inhibition of acetylcholinesterase. Journal of Agricultural and Food Chemistry. vol. 62. no. 9. pp. 2062-2068. 2014.
59. M. A. Papandreou, A. Dimakopoulou, Z. I. Linardaki, et al., "Effect of a polyphenol-rich wild blueberry extract on cognitive performance of mice, brain antioxidant markers and acetylcholinesterase activity. Behavioural Brain Research. vol. 198. no. 2. pp. 352-358. 2009.
60. M.-S. Garćia-Aylĺon, O. Cauli, M.-X. Silveyra, et al., "Brain cholinergic impairment in liver failure. Brain. vol. 131. no. 11. pp. 2946-2956. 2008.